French Glucose Monitor Removal Order Carried Out Over Industry Opposition
This article was originally published in The Gray Sheet
Executive Summary
A decision by the French government to implement its previously announced plan to remove from the market certain self-testing in vitro diagnostic blood glucose monitors apparently will not affect the offerings of Johnson & Johnson subsidiary LifeScan.